These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26554054)

  • 1. [Methotrexate may be a useful corticosteroid reducing treatment of severe asthma].
    Knarborg M; Hilberg O; Dahl R
    Ugeskr Laeger; 2015 Jun; 177(24):1159-63. PubMed ID: 26554054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Methotrexate may be a useful corticosteroid reducing treatment of severe asthma].
    Knarborg M; Hilberg O; Dahl R
    Ugeskr Laeger; 2014 Apr; 176(15):. PubMed ID: 25350142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate for the treatment of chronic corticosteroid-dependent asthma.
    Reid DJ; Segars LW
    Clin Pharm; 1993 Oct; 12(10):762-7. PubMed ID: 8258256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of oral methotrexate as a steroid sparing agent in refractory eosinophilic asthma.
    Bilocca D; Hargadon B; Pavord ID; Green RH; Brightling CE; Bradding P; Wardlaw AJ; Martin N; Murphy AC; Siddiqui S
    Chron Respir Dis; 2018 Feb; 15(1):85-87. PubMed ID: 28569072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate in the treatment of corticosteroid-dependent asthma. A double-blind crossover study.
    Mullarkey MF; Blumenstein BA; Andrade WP; Bailey GA; Olason I; Wetzel CE
    N Engl J Med; 1988 Mar; 318(10):603-7. PubMed ID: 3278232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of chronic persistent severe asthma: role of methotrexate].
    García Río FJ; Vázquez M; Satué JL
    Med Clin (Barc); 1993 Mar; 100(10):384-8. PubMed ID: 8474283
    [No Abstract]   [Full Text] [Related]  

  • 7. A risk-benefit assessment of methotrexate in corticosteroid-dependent asthma.
    Shulimzon TR; Shiner RJ
    Drug Saf; 1996 Oct; 15(4):283-90. PubMed ID: 8905253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate in the treatment of systemic glucocorticoid-dependent severe persistent asthma: a word of caution.
    Fabbri L; Caramori G; Cosma P; Ciaccia A
    Monaldi Arch Chest Dis; 1996 Apr; 51(2):130-7. PubMed ID: 8680380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing severe asthma in adults: lessons from the ERS/ATS guidelines.
    Chung KF
    Curr Opin Pulm Med; 2015 Jan; 21(1):8-15. PubMed ID: 25405672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate in the management of severe steroid dependent asthma.
    Taylor DR; Flannery EM; Herbison GP
    N Z Med J; 1993 Sep; 106(964):409-11. PubMed ID: 8377957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporin A treatment and airways inflammation in corticosteroid-dependent asthma.
    Redington AE; Hardinge FM; Madden J; Holgate ST; Howarth PH
    Allergy; 1998 Jan; 53(1):94-8. PubMed ID: 9491236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Methotrexate in the treatment of asthma. Open trial in 10 corticoid-dependent patients with severe asthma].
    Becquart LA; Wallaert B; Lassalle P; Guéné-Ribassin C; Tonnel AB
    Rev Mal Respir; 1994; 11(6):565-71. PubMed ID: 7831506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy-resistant asthma--a distinct phenotype?].
    Virchow JC
    Med Klin (Munich); 2006 Apr; 101(4):301-7. PubMed ID: 16607486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive therapy for asthma.
    Mullarkey M
    Allergy Proc; 1995; 16(2):81-4. PubMed ID: 7797064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficiency of methotrexate in the treatment of cortico-dependent asthmatic patients].
    Domingo Ribas C; Comet Monte R; Bosque García M; Morón Besolí A; Montón Soler C
    Rev Clin Esp; 1999 Mar; 199(3):142-6. PubMed ID: 10230292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of omalizumab on the need for rescue systemic corticosteroid treatment in patients with moderate-to-severe persistent IgE-mediated allergic asthma: a pooled analysis.
    Busse WW; Massanari M; Kianifard F; Geba GP
    Curr Med Res Opin; 2007 Oct; 23(10):2379-86. PubMed ID: 17711616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current management of asthma patients with corticosteroid resistance.
    Busse WW; McGill K; Jarjour NN
    Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 2):S70-2; discussion S72-3. PubMed ID: 8756793
    [No Abstract]   [Full Text] [Related]  

  • 18. Steroids and "steroid-sparing" agents in asthma.
    Cott GR; Cherniack RM
    N Engl J Med; 1988 Mar; 318(10):634-6. PubMed ID: 3344009
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral corticosteroid-dependent asthma: a 30-year review.
    Randhawa I; Klaustermeyer WB
    Ann Allergy Asthma Immunol; 2007 Oct; 99(4):291-302; quiz 302-3, 370. PubMed ID: 17941275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of symptom control with changes in lung function, bronchial hyperresponsiveness, and exhaled nitric oxide after inhaled corticosteroid treatment in children with asthma.
    Park GM; Han HW; Kim JY; Lee E; Cho HJ; Yoon J; Hong SJ; Yang SI; Yang HJ; Yu J
    Allergol Int; 2016 Oct; 65(4):439-443. PubMed ID: 27160342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.